Stories about Diabetic neuropathy
-
Language:
English
-
Media:
All
- Period:
- Period:Total
- more
Grünenthal and Averitas Pharma Announce U.S. FDA Approval of QUTENZA® for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy of the Feet
moreAveritas Pharma Announces FDA Acceptance of sNDA Filing for QUTENZA® (capsaicin) 8% Patch for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy
moreFive young scientists win EFIC-Grünenthal Grant 2018
moreGrünenthal acquires Averitas Pharma and establishes commercial footprint in the US
more
1